Chemotherapy Regimens: — What the Acronyms Mean
The acronym on your chemotherapy chart is a shorthand built from the first letters of each drug in your combination. This page expands every common regimen name, names the drugs inside it, and explains how the code was put together.
- An acronym, not a product — FOLFOX, CHOP and BEP are shorthand codes that oncologists, nurses and pharmacists use to refer to the same drug combination consistently.
- One letter, one drug — Most letters come from the generic name or older brand name of a drug in the combination. Some regimens mix both.
- Hyphens mean sequences — AC-T means two phases: the AC combination is given first, then T (paclitaxel, formerly sold as Taxol) follows in a separate second phase.
- Ask for the written list — Your oncologist can write out every drug in your regimen before your first cycle begins. It is a reasonable thing to ask for.
Medically reviewed by Dr. T. Raghavender Reddy, Medical Oncologist, MBBS · DM (Medical Oncology) · MD (Radiation Oncology) · Last reviewed September 2026
The acronym on your chemotherapy chart is built from the first letters of each drug in your combination. FOLFOX stands for Folinic acid, 5-Fluorouracil, and Oxaliplatin. CHOP stands for Cyclophosphamide, Hydroxydaunorubicin, Vincristine, and Prednisolone. Each letter is one drug your team has chosen for your specific cancer.
Why does your chart use an acronym instead of the drug names?
Most chemotherapy regimens combine two, three or four drugs because combinations reach cancer cells in different ways and at different points in the cell cycle. Writing out each full drug name every time would be unwieldy, so oncologists use a shorthand built from the first letters.
The acronym is not a brand or a product. It is a consistent code used by your oncologist, nurses, pharmacist and the hospital system to refer to the same combination without ambiguity.
Knowing what the letters stand for helps you ask more specific questions and understand what is being discussed in your appointments.
How is a chemotherapy acronym put together?
Each letter usually stands for one drug, taken from either the generic name or — for older regimens — the brand name that was in use when the combination was first designed. CHOP, for example, uses H from Hydroxydaunorubicin (the formal generic name for doxorubicin) and O from Oncovin (a former brand name for vincristine).
A prefix added before the main acronym usually signals an additional drug. R-CHOP adds R for rituximab, a monoclonal antibody, to the original CHOP combination. The dash or letter change signals that the added drug works by a different mechanism.
Hyphens or slashes indicate sequences — drugs given in a set order rather than all at once. AC-T means the AC combination is given first, then T (paclitaxel) follows in a separate second phase.
Who is chemotherapy not suitable for?
Your oncologist decides whether chemotherapy is appropriate for your specific situation. Several groups are not candidates, or may need significant modification:
- People with very poor general fitness or severe organ failure. Chemotherapy requires the body to metabolise powerful drugs. Severely reduced kidney, liver or heart function may make standard regimens unsafe.
- Patients at the very end of life. Where expected survival is very limited, the burden of treatment typically outweighs any possible benefit.
- Tumours that do not respond to chemotherapy. Some cancer types and subtypes are not sensitive to cytotoxic drugs. Biomarker testing helps identify these.
- Active uncontrolled infection. Chemotherapy suppresses the immune system. A serious active infection must usually be treated first.
- Pregnancy, in most cases. Many chemotherapy drugs are harmful to a developing foetus, particularly in the first trimester. This is discussed case by case.
Eligibility is always decided by an oncologist on the individual case, not by the regimen name or cancer type alone.
How do you find out exactly which drugs are in your regimen?
Ask your oncologist or treating nurse to write out each drug name beside its letter before you leave the consultation. Most teams do this routinely; if yours has not, it is entirely reasonable to ask.
Your hospital pharmacist also holds a complete list of every drug that will be prepared for you and can confirm the names and their generic equivalents.
Knowing the full names matters beyond curiosity. Your team needs to know every medicine, vitamin, herbal preparation or supplement you take, because some interact with chemotherapy drugs in ways that can affect either safety or effectiveness.
How to decode a regimen name on your paperwork
Write it down exactly
Copy the acronym precisely as it appears, including any hyphens, slashes or prefix letters. Small differences — CHOP versus R-CHOP — mean different regimens.
Ask for the expansion
Ask your oncologist or nurse to go through each letter and name the drug it stands for. Write both down side by side while you are still in the room.
Confirm the generic name
Ask for the generic drug name alongside any brand name. Generic names are what will appear on your pharmacy records, blood test forms and discharge summaries.
Ask about the cycle plan
Ask how many cycles are currently planned and when that number will be reviewed. Cycle counts are a working plan, not a fixed contract — they can change based on your response and how well you are tolerating treatment.
Bring your full medicines list
Tell your team every medicine, supplement, herbal preparation and over-the-counter drug you take before your first cycle begins. Some interact with chemotherapy.
Common chemotherapy regimen names expanded
FOLFOX — colorectal cancer and others
FOLFOX stands for Folinic acid (leucovorin), 5-Fluorouracil (5-FU), and Oxaliplatin. Folinic acid is not itself a chemotherapy drug — it is given to enhance the effect of 5-fluorouracil. Oxaliplatin is a platinum-based agent given intravenously. FOLFOX is most commonly used in colorectal cancer. The number of planned cycles varies by stage and response; ask your oncologist how many are planned for your situation rather than looking for a standard figure.
FOLFIRI — colorectal cancer
FOLFIRI stands for Folinic acid (leucovorin), 5-Fluorouracil, and Irinotecan. It uses the same folinic acid and 5-fluorouracil backbone as FOLFOX but replaces oxaliplatin with irinotecan, a different class of drug. FOLFIRI and FOLFOX may be used at different points in treatment, or one may follow the other. The choice depends on your specific situation, prior treatment history, and how your body tolerated earlier drugs.
FOLFIRINOX — pancreatic and colorectal cancer
FOLFIRINOX combines all four drugs: Folinic acid, 5-Fluorouracil, Irinotecan, and Oxaliplatin. The name is assembled from FOL (folinic acid), F (5-fluorouracil), IRIN (irinotecan) and OX (oxaliplatin). It is an intensive combination typically considered for patients with good general fitness. It is associated with a higher rate of side effects than simpler regimens, which is why a detailed fitness assessment takes place before it is recommended.
CHOP and R-CHOP — lymphoma
CHOP stands for Cyclophosphamide, Hydroxydaunorubicin (doxorubicin), Oncovin (vincristine), and Prednisolone. When rituximab — a monoclonal antibody that targets the CD20 protein on certain lymphoma cells — is added, the regimen becomes R-CHOP. R-CHOP is among the most widely used regimens in lymphoma treatment. Cycle counts are set in advance and reviewed after an interim assessment scan, typically partway through the planned course.
ABVD — Hodgkin lymphoma
ABVD stands for Doxorubicin (Adriamycin), Bleomycin, Vinblastine, and Dacarbazine. It has been a standard regimen for Hodgkin lymphoma for several decades, which is why it uses the Adriamycin brand name rather than the generic. All four drugs are given intravenously. Bleomycin carries a specific lung toxicity risk, so your team will monitor your breathing throughout treatment and may order lung function tests at intervals.
AC-T — breast cancer
AC-T is a sequential regimen, not a single combination given at the same time. AC stands for Doxorubicin (Adriamycin) and Cyclophosphamide, given together in the first phase. T stands for Taxol — the brand name for paclitaxel — given in a separate second phase after AC is complete. The hyphen in the name signals the sequence. A related version uses docetaxel instead of paclitaxel and may appear as AC-D or AC-Doc on your paperwork.
BEP — germ cell tumours and testicular cancer
BEP stands for Bleomycin, Etoposide, and Cisplatin (formerly marketed as Platinol, which provides the P). It is used most commonly in germ cell tumours, including testicular cancer. Cisplatin is given intravenously and requires careful hydration before and after each administration to protect the kidneys — your nurses will manage this as part of each treatment day. Bleomycin carries a lung toxicity risk your team will monitor throughout.
CAPOX / XELOX — colorectal and gastric cancer
CAPOX and XELOX are two names for the same regimen: Capecitabine and Oxaliplatin. Capecitabine — sold under the brand name Xeloda, which gives XELOX its name — is an oral tablet taken at home on a schedule your team will write out for you. Oxaliplatin is given intravenously in the clinic. Because part of your treatment happens outside the hospital, your team will give you written instructions on timing, storage and what to watch for between visits.
GC — lung, bladder and biliary cancers
GC stands for Gemcitabine and Cisplatin. It is used across several cancer types, including non-small-cell lung cancer, bladder cancer, and cancers of the bile duct and gallbladder. Both drugs are given intravenously. Cisplatin requires hydration before and after administration. Some patients receive carboplatin instead of cisplatin — the same class of platinum drug — if kidney function or other factors make cisplatin unsuitable. Your oncologist will specify which platinum agent is in your plan.
FEC — breast cancer
FEC stands for 5-Fluorouracil, Epirubicin, and Cyclophosphamide. Epirubicin is a red-coloured drug that may turn urine pink or red for a day or two after treatment — this is expected and not a cause for alarm. FEC is sometimes followed by a taxane drug in a sequential plan, written FEC-T or FEC-D depending on which taxane follows. The number of FEC cycles before any switch is set out in your individual treatment plan.
ECF / ECX — gastric and oesophageal cancer
ECF stands for Epirubicin, Cisplatin, and 5-Fluorouracil. ECX replaces the continuous-infusion 5-fluorouracil component with oral capecitabine (Xeloda), which achieves a similar effect without requiring a portable infusion pump to be worn at home. Both are used in cancers of the stomach and oesophagus. The choice between ECF and ECX depends on your oncologist's assessment of which delivery method suits your situation and how you are likely to tolerate each.
CMF — breast cancer (older regimen)
CMF stands for Cyclophosphamide, Methotrexate, and 5-Fluorouracil. It is an older regimen that predates the anthracycline-based combinations more commonly used today. It may still be chosen in specific situations — for example, where cardiac considerations make doxorubicin or epirubicin unsuitable. If you see CMF on your paperwork and were not expecting it, ask your oncologist to explain the reasoning, as it will be specific to your individual circumstances.
Explore 82 more How Chemotherapy Is Given: Regimens, Cycles & Infusion Days topics
Chemotherapy Regimens by Name
- 7+3 and Induction Regimens for Acute Leukaemia
- ABVD Regimen for Hodgkin Lymphoma
- AC and EC Regimens
- AC-T Regimen for Breast Cancer
- BEP Regimen for Testicular and Germ Cell Cancer
- CAPOX and XELOX Regimens
- CHOP Without Rituximab
- Carboplatin-Paclitaxel Regimen
- Cervical Cancer Chemotherapy and Chemoradiation Regimens
- Chemotherapy Regimens: What the Acronyms Mean
- Cisplatin-Pemetrexed and Platinum-Pemetrexed
- Comparing Two Regimens: How the Choice Is Made
- DCF and FLOT Regimens for Stomach Cancer
- Doxorubicin-Ifosfamide and Sarcoma Regimens
- EP and Carboplatin-Etoposide for Small Cell Lung Cancer
- FEC and CMF Regimens
- FOLFIRI Regimen
- FOLFIRINOX and Modified FOLFIRINOX
- FOLFOX Regimen for Colorectal Cancer
- GemCis and MVAC for Bladder Cancer
- Gemcitabine-Nab-Paclitaxel for Pancreatic Cancer
- R-CHOP Regimen for Lymphoma
- Salvage Lymphoma Regimens: ICE, DHAP and ESHAP
- TC Regimen (Docetaxel and Cyclophosphamide)
- TPF and Cisplatin Regimens for Head and Neck Cancer
- VRd, VCd and Myeloma Regimens
- Weekly Cisplatin With Radiation (Chemoradiation)
- Which Regimen Is Used for Which Cancer?
Cycle Delays, Dose Reductions & Changes
- Does a Delay Mean the Cancer Is Growing?
- Does a Reduced Dose Still Work?
- Growth Factor Support to Keep the Schedule
- How Many Delays Are Too Many?
- Infection Delaying a Cycle
- My Counts Were Too Low and the Cycle Was Postponed
- Organ Function Problems Delaying a Cycle
- Stopping Early: What Happens If You Do Not Complete the Course?
- Transfusion During Chemotherapy
- What If I Cannot Tolerate the Treatment?
- What Is a Dose Reduction and Why Was Mine Reduced?
- What to Ask If Your Plan Changes
- Why Chemotherapy Gets Delayed or Reduced
- Why Was My Regimen Switched?
HUB — Chemotherapy Regimens
HUB — Cycles, Schedules and What Happens on Infusion Day
How Chemotherapy Is Given
- Can Chemotherapy Be Given at Home?
- Can Chemotherapy Be Given at a Local Hospital?
- Continuous Infusion Chemotherapy and Portable Pumps
- Day Care vs Admission for Chemotherapy
- How Is Chemotherapy Given? All the Routes Explained
- How Long Does Each Chemotherapy Session Take?
- Intra-Arterial and Regional Chemotherapy
- Intraperitoneal Chemotherapy
- Intrathecal Chemotherapy: Into the Spinal Fluid
- Intravenous Chemotherapy: What the Drip Involves
- Intravesical Chemotherapy for the Bladder
- Is Oral Chemotherapy Weaker Than Injections?
- Oral Chemotherapy: Tablets Instead of a Drip
- Subcutaneous and Intramuscular Chemotherapy
- Topical Chemotherapy Creams
- What Safety Checks Happen Before Each Dose?
- Who Actually Gives Your Chemotherapy?
- Why Does the Route Sometimes Change During Treatment?
Regimens, Cycles & Schedules
- A Printable Chemotherapy Cycle Calendar
- Adding or Removing Cycles Mid-Course
- Blood Tests Before Every Cycle: What They Check
- Day 1, Day 8, Day 15: What the Day Numbers Mean
- Does Delaying a Cycle Reduce the Benefit?
- How Many Cycles Before the First Assessment?
- How the Dose Is Calculated for You
- Keeping a Chemotherapy Symptom Diary
- Planning Your Life Around Chemotherapy Cycles
- Rescheduling or Missing a Chemotherapy Appointment
- Weekly, Two-Weekly and Three-Weekly Schedules
- What Happens Between Cycles?
- What Happens at the Last Cycle?
- What Is Dose Intensity?
- What Is a Chemotherapy Cycle?
- What Is the Nadir and Why Does It Matter?
- Which Days of the Cycle Will I Feel Worst?
- Why Was My Cycle Postponed?
The Infusion Day
Your First Cycle
All How Chemotherapy Is Given: Regimens, Cycles & Infusion Days →
Frequently asked questions
If two people have the same acronym on their charts, are they getting the same treatment?
Usually the same drugs, but not necessarily the same plan. Two patients receiving FOLFOX are getting the same three drugs, but their cycle counts, intervals, and how the drugs are adjusted relative to body size and kidney function may differ. The acronym tells you which drugs are in the combination. Your treatment plan tells you how those drugs are being given to you specifically. Both pieces of information matter.
What does 'cycle' mean — and how many will I need?
A cycle is one complete course of treatment followed by a rest period that allows your body to recover before the next round. Some cycles run every two weeks, others every three. The number planned for you depends on your cancer type, stage, how well you are tolerating treatment, and how your cancer is responding. Your oncologist sets a starting number and reviews it as treatment progresses — cycles can be added, reduced or stopped depending on what happens.
Why does a regimen sometimes have more than one name, like CAPOX and XELOX?
Because the same drug combination can be named from different letters. CAPOX uses the generic name Capecitabine; XELOX uses Xeloda, the brand name for the same drug. Both names refer to the same two-drug combination: capecitabine and oxaliplatin. You may see either on paperwork from different hospitals or systems. If you see a name you have not seen before, ask your team to confirm it is the same regimen you have been receiving — a small spelling difference can sometimes mean a different plan.
Can I ask for a different regimen?
You can always ask why a particular regimen was chosen and what the alternatives were. Your oncologist will explain the reasoning — usually it reflects your cancer type, stage, biomarker results, prior treatment and general fitness. Switching to a different regimen is possible in some situations, but the choice is a clinical one based on the evidence for your specific cancer. Asking the question is entirely appropriate. The decision is made jointly with your team, with your individual situation as the starting point.
What happens if one of the drugs in my regimen has to be removed or changed?
It happens more often than people expect. If a drug causes an unacceptable side effect — a nerve toxicity, an allergic reaction, or stress on the kidneys or heart — it can be reduced, temporarily held, or replaced with a different drug from the same class. Your regimen may be referred to differently if the combination changes. The goal is to keep effective treatment going in a form your body can tolerate, not to follow the original plan at all costs. Tell your team about any new or worsening symptom rather than waiting for your next scheduled appointment.
Does a longer or more complicated acronym mean stronger or harsher treatment?
No. The length of the acronym reflects the number of drugs in the combination, not how aggressive or difficult the treatment will be. FOLFIRINOX has four components; BEP has three. Side effect burden depends on the specific drugs used, the dose relative to your body size, and how your body responds to them — not on how many letters are in the name. Your team will go through the expected side effects of your specific regimen in detail before you start, and you should feel free to ask about any that concern you.
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Where to find us
Our centres in and around Hyderabad
Addressed by landmark, because that is how this city navigates. Each centre also names the areas it serves, so you can place it without a map. Consultation and day-care Chemotherapy run at every one of them.
Chemotherapy Topics
Browse our complete chemotherapy guide — 1133 pages on side effects, medicines, cost, daily life and care in Hyderabad. Tap any topic to read more.